This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Samuel Gershon, MD; Jair C. Soares, MD
Department of Psychiatry Western Psychiatric Institute and Clinic University of Pittsburgh Medical Center 3811 O'Hara St Pittsburgh, PA, 15213

Arch Gen Psychiatry. 1997;54(1):16-20.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WITH The advent of new pharmacotherapies for bipolar disorder, it may be an opportune time to look at the course of events that initiated the possibility of specific pharmacotherapy for this disorder. It is now 48 years since Cade's original report about the effects of lithium carbonate treatment in cases of mania was published.¹ The time course of lithium therapy introduction in 1949, and its subsequent development, is concomitant with the span of the professional career of one of us (S.G.). The article by Schou² in this issue of the ARCHIVES raises several key points that we would like to address.

MAGNITUDE OF LITHIUM EFFECTIVENESS IN MANIA

The early studies of lithium in the treatment of acute mania reported high effectiveness. In Cade's initial open study,¹ all 10 patients with mania clearly responded to lithium administration. In subsequent, controlled studies, high (~70%-80%), effectiveness of lithium therapy . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?